Medical Device News Magazine

UCI Urology Team Developing Unique Endoscope to Improve Kidney Stone Surgery

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

UCI Urology (four Urologists), who specialize in kidney stone diseases include Dr. Pengbo Jiang, Dr. Jaime Landman, Dr. Roshan Patel, and Dr. Ralph V. Clayman, have teamed up with UCI CALIT2 engineers, Dr. William Mao, Dr. Mike Klopfer, and G. P. Li to design a new ureteroscope that is capable of removing all kidney stone fragments during surgery.

The team has six months to complete the project and has received a grant to develop the technology.

UCI Urology, Team Developing Unique Endoscope to Improve Kidney Stone Surgery
UCI Urology Team Developing Unique Endoscope to Improve Kidney Stone Surgery

Approximately 10% of the U.S. population will experience a kidney stone. The primary treatment goals are to remove the stone with the least amount of patient discomfort and to prevent recurrence. One of the least invasive options for surgery involves using a non-incisional approach by entering the urinary tract with a ureteroscope. This type of endoscopic approach allows the urologist to access a stone and use a laser to break the stone into fragments.

Unfortunately, with the current technology, many of the smallest fragments cannot be recovered and removed. In fact, with the ureteroscope, even the best stone clearance rates are no better than 50 to 60%. The remaining fragments (about 2mm or smaller in size) can contribute to the formation of recurring stones within two years in as many as 40% of patients.

The UCI team seeks to develop instrumentation that is able to leave the kidney fragment-free following stone removal. The team’s proposal has been awarded a UCI Beall Applied Innovation Proof of Product (POP) grant, a funding program that accelerates commercially promising technology.

Dr. Ralph Clayman stated, “The POP grant has empowered and energized our work in this area. I am optimistic that given the great partnership we have with CALIT2 and the School of Engineering, within six months we will have a working prototype. This work has the potential to vastly improve surgical outcomes for all patients with kidney stones.”

The team has six months to complete this project and will utilize the Surgical Education and Research Center located at UCI Medical Center, Orange, CA. If successful, a disposable ureteroscope will be created that is able to remove all stone fragments, regardless of size. The ureteroscope will have additional features designed to improve the efficiency and effectiveness of stone removal, such as multiple laser channels and multidirectional deflection.

UCI Urology is at the forefront of research, providing patients with the best in innovative and less invasive urologic care. The department has a core mission to discover new advances in healthcare, teach tomorrow’s medical professionals, and heal patients with individualized care.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”